Volume 20, Number 6—June 2014
Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis
|Study end point||Antifungal treatment
|Yes, n = 20||No, n = 16|
|Time to 50% reduction in symptom score, wk||0.84†|
|Q1, Q3||7.0, 13.4||7.4, 17.1|
|Time to complete symptom resolution, wk||0.65‡|
|Q1, Q3||13.6, 25.0||12.1, 24.0|
|Time to 50% reduction in fatigue, wk§||0.59‡|
|Q1, Q3||8.0, 16.0||8.4, 15.9|
|Time to full attendance at work, wk||0.02†|
|Q1, Q3||6.7, 14.8||5.1, 6.0|
|Time to full attendance at school, wk|
|Time to 50% improvement in PCS, wk||0.08‡|
|Time to 50% improvement in MCS, wk||0.21‡|
|Q1, Q3||9.3, 14.7||6.6, 9.7|
*Q1, first quartile; Q3, third quartile; PCS, physical activity score as measured on the SF-36 General Health Survey; MCS, mental activity score as measured on the SF-36 General Health Survey.
†By the Wilcoxon rank–sum test.
‡By the equal variance t test.
§As reported on the Fatigue Severity Scale.